LivaNova (LIVN) Return on Capital Employed (2016 - 2026)
LivaNova's (LIVN) quarterly Return on Capital Employed came in at 10.69% in Q1 2026, up 167.0% year-on-year from 4.0% in Q1 2025, and down 4.92% quarter-over-quarter from 11.24% in Q4 2025.
LivaNova (LIVN) Return on Capital Employed (2016 - 2026) Analysis & Trends
LivaNova has disclosed Return on Capital Employed across 11 years of filings, most recently posting 10.69% for Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 10.69%, up 167.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 10.69% (up 167.0% YoY), and the FY2025 annual result was 11.41%, up 519.0% from the prior year.
- Return on Capital Employed came in at 10.69% for Q1 2026 at LivaNova, down from 11.24% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 11.37% in Q3 2025 to a low of 5.07% in Q2 2023.
- The 5-year median for Return on Capital Employed is 0.72% (2022), against an average of 2.4%.
- Across the five-year window, Return on Capital Employed surged 2167 bps in 2022 and sank 897 bps in 2023, its largest moves.
- LivaNova's Return on Capital Employed stood at 3.92% in 2022, then grew by 15 bps to 3.35% in 2023, then jumped by 282 bps to 6.08% in 2024, then surged by 85 bps to 11.24% in 2025, then slipped by 5 bps to 10.69% in 2026.
- The last three Return on Capital Employed figures came in at 10.69% (Q1 2026), 11.24% (Q4 2025), and 11.37% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | LivaNova | 4.29 Bn | 3.71 Bn | 243.75 Mn | 10.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.69% |
| Dec 31, 2025 | 11.24% |
| Sep 30, 2025 | 11.37% |
| Jun 30, 2025 | 10.29% |
| Mar 31, 2025 | 9.01% |
| Dec 31, 2024 | 6.08% |
| Sep 30, 2024 | 0.30% |
| Jun 30, 2024 | -2.00% |
| Mar 31, 2024 | -2.36% |
| Dec 31, 2023 | -3.35% |
| Sep 30, 2023 | 1.64% |
| Jun 30, 2023 | -5.07% |
| Mar 31, 2023 | -4.48% |
| Dec 31, 2022 | -3.92% |
| Sep 30, 2022 | -3.32% |
| Jun 30, 2022 | 3.90% |
| Mar 31, 2022 | 0.72% |
| Dec 31, 2021 | -0.05% |
| Sep 30, 2021 | -16.73% |
| Jun 30, 2021 | -17.76% |